These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 3485067)

  • 1. Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.
    Chapman RW; Cottone M; Selby WS; Shepherd HA; Sherlock S; Jewell DP
    Gut; 1986 Jan; 27(1):86-91. PubMed ID: 3485067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of primary sclerosing cholangitis with HLA-B8.
    Chapman RW; Varghese Z; Gaul R; Patel G; Kokinon N; Sherlock S
    Gut; 1983 Jan; 24(1):38-41. PubMed ID: 6600227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile duct antibodies crossreacting with blood group antigens in primary sclerosing cholangitis.
    Jeffrey GP; Swanson NR; Yarred LJ; Reed WD
    Gut; 1990 Jun; 31(6):698-701. PubMed ID: 2199348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary sclerosing cholangitis--an immunologically mediated disease?
    Chapman RW; Jewell DP
    West J Med; 1985 Aug; 143(2):193-5. PubMed ID: 4036118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
    Duerr RH; Targan SR; Landers CJ; LaRusso NF; Lindsay KL; Wiesner RH; Shanahan F
    Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.
    Peen E; Almer S; Bodemar G; Rydén BO; Sjölin C; Tejle K; Skogh T
    Gut; 1993 Jan; 34(1):56-62. PubMed ID: 8432453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA antigens in ulcerative colitis and primary sclerosing cholangitis.
    Leidenius MH; Koskimies SA; Kellokumpu IH; Höckerstedt KA
    APMIS; 1995; 103(7-8):519-24. PubMed ID: 7576567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
    Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH
    Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An autoantibody profile in primary sclerosing cholangitis.
    Zauli D; Schrumpf E; Crespi C; Cassani F; Fausa O; Aadland E
    J Hepatol; 1987 Aug; 5(1):14-8. PubMed ID: 3498749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.
    Seibold F; Slametschka D; Gregor M; Weber P
    Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunologic parameters in pericholangitis and primary sclerosing cholangitis with and without ulcerative colitis].
    Hopf U; Riecken EO; Zeitz M; Eckhardt R; Lobeck H; Malchus R; Möller B
    Dtsch Med Wochenschr; 1983 Oct; 108(40):1515-21. PubMed ID: 6617507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and tissue autoantibodies to colonic epithelium in ulcerative colitis.
    Snook JA; Lowes JR; Wu KC; Priddle JD; Jewell DP
    Gut; 1991 Feb; 32(2):163-6. PubMed ID: 1864535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological studies in ulcerative colitis. VIII. Antibodies to colon antigen in patients with ulcerative colitis, Crohn's disease, and other diseases.
    Carlsson HE; Lagercrantz R; Perlmann P
    Scand J Gastroenterol; 1977; 12(6):707-14. PubMed ID: 73216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin G subclass distribution of human anticolon antibodies in ulcerative colitis.
    Ohara M; Hibi T; Watanabe N; Kobayashi K; Takaishi H; Hayashi A; Hosoda Y; Toda K; Iwao Y; Watanabe M
    J Gastroenterol Hepatol; 1995; 10(2):158-64. PubMed ID: 7787161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis.
    Bansi DS; Lo S; Chapman RW; Fleming KA
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):111-6. PubMed ID: 8723413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro anticolon antibody production by mucosal or peripheral blood lymphocytes from patients with ulcerative colitis.
    Hibi T; Ohara M; Toda K; Hara A; Ogata H; Iwao Y; Watanabe N; Watanabe M; Hamada Y; Kobayashi K
    Gut; 1990 Dec; 31(12):1371-6. PubMed ID: 2176171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment.
    Oudkerk Pool M; Ellerbroek PM; Ridwan BU; Goldschmeding R; von Blomberg BM; Peña AS; Dolman KM; Bril H; Dekker W; Nauta JJ
    Gut; 1993 Jan; 34(1):46-50. PubMed ID: 8432451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
    Snook JA; Chapman RW; Fleming K; Jewell DP
    Clin Exp Immunol; 1989 Apr; 76(1):30-3. PubMed ID: 2786779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases.
    Claise C; Johanet C; Bouhnik Y; Kapel N; Homberg JC; Poupon R
    Liver; 1996 Feb; 16(1):28-34. PubMed ID: 8868075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical studies on the class and the subclass of the anticolon antibody and the distribution of the antigen recognized by the anticolon antibody in patients with ulcerative colitis.
    Kanzaki K; Mizuno M; Tsuji T
    Acta Med Okayama; 1991 Aug; 45(4):249-56. PubMed ID: 1962532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.